Abstract
Aims: To estimate the cost‐effectiveness of training in flexible intensive insulin therapy [as provided in the Dose Adjustment for Normal Eating (DAFNE) structured education programme] compared with no training for adults with Type 1 diabetes mellitus in theUKusing the Sheffield Type 1 Diabetes Policy Model.Methods: The Sheffield Type 1 Diabetes Policy Model was used to simulate the development of long‐term microvascular and macrovascular diabetes‐related complications and the occurrence of diabetes‐related adverse events in 5000 adults with Type 1 diabetes. Total costs and quality‐adjusted life years were estimated from a National Health Service perspective over a lifetime horizon, discounted at a rate of 3.5%. The treatment effectiveness ofDAFNEwas modelled as a reduction in HbA1cthat affected the risk of developing long‐term diabetes‐related complications. Probabilistic and structural sensitivity analyses were conducted.Results: DAFNEresulted in greater life expectancy and reduced incidence of some diabetes‐related complications compared with noDAFNE.DAFNEwas found to generate an average of 0.0294 additional quality‐adjusted life years for an additional cost of £426 per patient, leading to an incremental cost‐effectiveness ratio of £14 400 compared with noDAFNE. There was a 54% probability thatDAFNEwould be cost‐effective at a willingness‐to‐pay threshold of £20 000 per quality‐adjusted life year.Conclusions: The results of this study suggest thatDAFNEis a cost‐effective structured education programme for people with Type 1 diabetes and support its provision by the National Health Service in theUK.

This publication has 20 references indexed in Scilit: